Company

RESEARCH TRIANGLE PARK, NC (October 22, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into a market that will transform the lives of people living
with SCI’. Under the SCI Accelerate program, Dignify and Praxis will focus on the development of Dignify’s drug programs to treat bladder and bowel disorders in people with SCI.

Dr. Karl B. Thor, Chief Scientific Officer of Dignify, indicated; “The Praxis SCI Accelerate Program is critically important for Dignify to ensure that the clinical development program for our products provides the efficacy, safety, and convenience that are considered valuable and most important by SCI individuals for control of bowel
and bladder dysfunction. The selection of Dignify to join the Praxis SCI community confirms the unmet medical need for our therapeutics.”

Arushi Raina, Praxis Director of Commercialization, stated “The Praxis team was impressed by the Dignify team’s approach and excited by the possibility of a bowel and bladder treatment that could be used in an accessible way to transform daily living.”

About Dignify Therapeutics
Founded by a team of serial entrepreneurs who are internationally recognized scientists and clinicians, Dignify’s mission is to provide safe, effective, practical, and convenient, “on-demand” pharmaceutical agents to treat bladder and bowel voiding dysfunctions. The company has been funded by RA Capital Management, Eshelman
Ventures, the North Carolina Biotechnology Center, NIDDK, NINDS, NICHD, NIA, US Defense Department, and the One NC Small Business Program. Dignify is located at the First Flight Venture Center in Research Triangle Park, North Carolina.

About Praxis
Praxis is a Canadian-based not-for-profit organization that leads global collaboration in SCI research, innovation, and care. We accelerate the translation of discoveries and best practices into improved treatments for people with spinal cord injuries. Our work is driven by the priorities of people with SCI and led by our four teams — PLEX (people with lived experience), Cure, Care, and Commercialization.

PRESS CONTACT
Dignify Therapeutics
Anthony DiTonno, CEO
2 Davis Drive
Research Triangle Park, NC 27709
ditonno@dignifytherapeutics.com
dignifytherapeutics.com